ECE2021 Audio Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (223 abstracts)
1Kocaeli Derince Training and Research Hospital, Endocrinology, Derince/Kocaeli, Turkey; 2Dokuz Eylül University School of Medicine, Oncology, Turkey
Introduction
Gestational diabetes mellitus (GDM) may frequently be overcome by nutrition therapy alone, but insulin regimen may be necessary in about 30 % of the patients with GDM. It was known that thyroid hormones were associated with glucose metabolism. Therefore, we aimed to investigate the association of fT4 level with insulin requirement in euthyroid pregnant women with GDM.
Materials and methods
We consecutively included euthyroid patients with GDM, and excluded those with thyroid dysfunction or any previous history of use of levothyroxine or antithyroid drug. The diagnosis of GDM was based on ADA criteria. Demographic features, previous history of GDM, gestational hypertension, insulin requirement (absent vs present or basal vs intensive regimen) and dose, nutrition and exercise adherence, and HbA1c, TSH, fT4, fT3, 25(OH) vitamin D3 levels were analyzed. We grouped the patients according to fT4 levels: lower than mid-normal (group A) vs upper than mid-normal (group B), or lower than normal range vs in normal range. We assessed the patients in 3rd trimester after 34th weeks of the pregnancy.
Results
Of total (n = 228), insulin was necessary in 58 patients. Insulin use was more frequent in the patients with fT4 level lower than normal range than those with normal fT4 (P = 0.003, OR:5.69 (95% CI 1.6020.24)). Number of insulin injections was higher in group A than group B (0.022). fT4 level was not associated with insulin dose, HbA1c level, previous history of GDM, or diet adherence.
Conclusion
Lower fT4 level even in normal range may worsely affect glucose metabolism in euthyroid pregnant women with GDM. Our findings suggest that euthyroid hypothyroxinemia in pregnancy may be associated with difficulty in control of hyperglycemia. GDM would be an indication for treatment with levothyroxine in euthyroid hypothyroxinemia.
Insulin use | |||
Parameters | Absent (n = 170) | Present (n = 58) | p value |
X(±SD) | |||
Age(year) | 31.75(4.86) | 31.97(4.49) | 0.793 |
Gravida | 2.04(1.03) | 2.19(1.17) | 0.471 |
Parity | 0.87(0.88) | 1.0(0.95) | 0.385 |
Insulin dose(U/day) | NA | 19.60(13.27) | NA |
HbA1c(%) | 5.26(0.44) | 5.58(0.64) | 0.003 |
TSH(miu/l) | 1.50(0.80) | 1.69(0.80) | 0.104 |
fT4(ng/dl) | 0.95(0.13) | 0.93(0.13) | 0.689 |
fT3(pg/ml) | 2.58(0.48) | 2.69(0.41) | 0.071 |
25(OH) vitamin D3(ng/ml) | 15.87(9.14) | 16.90(6.95) | 0.453 |
N | |||
Hypertension(absence/presence) | 169/1 | 55/3 | 0.022 |
Previous GDM(absence/presence) | 156/14 | 51/7 | 0.383 |
Diet adherence(absence/presence) | 3/167 | 4/54 | 0.050 |
Exercise adherence(absence/presence) | 119/51 | 33/25 | 0.068 |
Insulin use(absence/presence) | |||
Number of insulin injections(≥2/ > 2 per day) | |||
HbA1c(< 5.7/≥ 5.7 %) | 135/35 | 39/19 | 0.060 |
HbA1c(< 6.5/≥ 6.5 %) | 169/1 | 49/9 | 0.001 |
TSH(< 2.65/≥ 2.65 miu/l) | 155/15 | 51/7 | 0.470 |
fT4(< 1.09/≥ 1.09 ng/dl) | 146/24 | 50/8 | 0.951 |
fT4(in normal range/lower than normal range) | 166/4 | 51/7 | 0.003 |